Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,617 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 26 locations
View Trial Details
Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

NCT05852717

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

NCT05077527

Conditions
AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, Blood-Borne Infections, +36 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Montefiore Medical Center - Moses Campus The Bronx, New York, United States
View Trial Details
Recruiting

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT06015880

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details

Related conditions